These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 11280767

  • 1. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
    Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ.
    Cancer Res; 2001 Mar 01; 61(5):2062-70. PubMed ID: 11280767
    [Abstract] [Full Text] [Related]

  • 2. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL.
    Vaccine; 2004 Jul 29; 22(21-22):2894-903. PubMed ID: 15246626
    [Abstract] [Full Text] [Related]

  • 3. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD.
    Cancer Res; 2002 Nov 15; 62(22):6545-51. PubMed ID: 12438249
    [Abstract] [Full Text] [Related]

  • 4. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
    Hisada M, Yoshimoto T, Kamiya S, Magami Y, Miyaji H, Yoneto T, Tamada K, Aoki T, Koyanagi Y, Mizuguchi J.
    Cancer Gene Ther; 2004 Apr 15; 11(4):280-8. PubMed ID: 15002032
    [Abstract] [Full Text] [Related]

  • 5. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 6. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
    Kikuchi T, Miyazawa N, Moore MA, Crystal RG.
    Cancer Res; 2000 Nov 15; 60(22):6391-5. PubMed ID: 11103803
    [Abstract] [Full Text] [Related]

  • 7. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y, Saxena A, Zheng C, Carlsen S, Xiang J.
    J Gene Med; 2004 Aug 15; 6(8):857-68. PubMed ID: 15293344
    [Abstract] [Full Text] [Related]

  • 8. Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity.
    Liang CM, Zhong CP, Sun RX, Liu BB, Huang C, Qin J, Zhou S, Shan J, Liu YK, Ye SL.
    J Virol; 2007 Sep 15; 81(17):9502-11. PubMed ID: 17567706
    [Abstract] [Full Text] [Related]

  • 9. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
    Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE.
    Cancer Res; 2003 Dec 01; 63(23):8466-75. PubMed ID: 14679011
    [Abstract] [Full Text] [Related]

  • 10. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
    Ribas A, Butterfield LH, Amarnani SN, Dissette VB, Kim D, Meng WS, Miranda GA, Wang HJ, McBride WH, Glaspy JA, Economou JS.
    Cancer Res; 2001 Dec 15; 61(24):8787-93. PubMed ID: 11751400
    [Abstract] [Full Text] [Related]

  • 11. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X.
    Gene Ther; 2002 Jun 15; 9(12):793-803. PubMed ID: 12040461
    [Abstract] [Full Text] [Related]

  • 12. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Sharma S, Stolina M, Zhu L, Lin Y, Batra R, Huang M, Strieter R, Dubinett SM.
    Cancer Res; 2001 Sep 01; 61(17):6406-12. PubMed ID: 11522634
    [Abstract] [Full Text] [Related]

  • 13. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 15. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice.
    Warren P, Song W, Holle E, Holmes L, Wei Y, Li J, Wagner T, Yu X.
    Anticancer Res; 2002 Apr 15; 22(2A):599-604. PubMed ID: 12014627
    [Abstract] [Full Text] [Related]

  • 16. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
    Lu J, Zhang Q, Liang CM, Xia SJ, Zhong CP, Wang DW.
    Asian J Androl; 2008 Nov 15; 10(6):883-9. PubMed ID: 18958352
    [Abstract] [Full Text] [Related]

  • 17. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W, He L, Cao X.
    Zhonghua Yi Xue Za Zhi; 1999 Mar 15; 79(3):170-3. PubMed ID: 11601032
    [Abstract] [Full Text] [Related]

  • 18. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency.
    Yoshikawa T, Niwa T, Mizuguchi H, Okada N, Nakagawa S.
    Gene Ther; 2008 Oct 15; 15(19):1321-9. PubMed ID: 18480845
    [Abstract] [Full Text] [Related]

  • 19. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
    Sun Y, Peng D, Lecanda J, Schmitz V, Barajas M, Qian C, Prieto J.
    Gene Ther; 2000 Sep 15; 7(17):1467-76. PubMed ID: 11001366
    [Abstract] [Full Text] [Related]

  • 20. Soluble expression of recombinant human secondary lymphoid chemokine (SLC) in E. coli and research on its in vitro and in vivo bioactivity.
    Chun L, Yin CC, Song JZ, Liu MX, Piao JH, Lin Q, Wang XB, Huang HL.
    J Biochem; 2004 Dec 15; 136(6):769-76. PubMed ID: 15671487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.